Eli Lilly’s US$3.8 Billion Bet Shows Psychedelic Medicine Has Entered a New Era
When Eli Lilly agreed to acquire Atai Beckley in a deal worth up to US$3.8 billion, it wasn't simply the ...
When Eli Lilly agreed to acquire Atai Beckley in a deal worth up to US$3.8 billion, it wasn't simply the ...
Psychedelics.media delivers trusted news, intelligence, and insights for the global psychedelic medicine industry.
